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chromatography in procedure which took two working days. The
enzyme was obtained with a yield of 30.8%. The overall purifica-
tion was about 5882 fold. The effect of temperature and opti-
mum pH of the enzyme activity was also examined. And we
observed the pH curve has more than one maximum value
(mainly at pH 8.0 and pH 9.5). This type of curve may be seen
for diprotic systems and indicate that the active site of the
enzyme may contain several ionizable groups.
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Diabetes is a widespread disease representing an enormous part
of the total health costs. An early diagnostic could be of extre-
mely importance both for the understanding and prevention of
this pathology. Saliva is a fluid with increasing interest as a
source of biomarkers for disease diagnostic and saliva protein
composition changes have already been reported for diabetic
individuals. However, the studies were performed after the onset
of the disease and it is unknown if salivary changes are present
in the early stages of development of the disease or a characteris-
tic of overt diabetes. Wistar rats have been selected for their glu-
cose intolerance (GIR). GIR females were compared with Wistar
females with normal glucose tolerance (control) for changes in
saliva protein composition and salivary gland histology. Fasting
glycemias were observed to be normal (<95 mg/dl) in GIR ani-
mals, indicating an absence of a diabetic state. However they pre-
sented an abnormal increase in glycemia after a glucose bolus.
For salivary parameters a marked increase in total protein con-
centration and alpha-amylase activity occurred in GIR animals,
comparatively to controls. After separation of salivary proteins
by SDS PAGE differences between the experimental groups for
some protein bands, with apparent molecular masses ranging
from 20 to 55 kDa were observed. Different expression of alpha-
amylase at salivary gland duct level is also apparent for pre-dia-
betic animals. Although preliminary, these results suggest changes
in saliva occurring before the onset of diabetes, reinforcing the
interest of further investigation of saliva composition for the
diagnostic of pre-diabetic condition, ultimately allowing an early
intervention and eventually the prevention of disease develop-
ment.
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Introduction: Nanotechnology has lead to an improvement in
the diagnostics techniques and treatment of several diseases,
using nanoparticles which transport the therapeutic agent specifi-
cally to the pathological area. Among many possible applica-
tions, tumors have been the most often investigated. Thyroid
cancer is the most frequent endocrine neoplasm, and although
differentiated cancers have in general a very good outcome,
undifferentiated tumors, as in the case of anaplastic thyroid can-
cer, are more aggressive and do not respond to treatment. Our
long term goal is to develop a targeted drug delivery system for
thyroid cancer treatment, and for this purpose, we have first
focused our work in the evaluation in cell cultures of polymer
nanocarriers directed to potential targets on the surface of thy-
roid cells by fluorescence microscopy.
Experimental Methods: Model polymer nanocarriers (NCs)
were prepared by coating green fluorescent polystyrene spheres
(100 nm) by surface adsorption with different antibodies against
the thyrotropin receptor (TSHR), and the epidermal growth fac-
tor receptor (EGFR), which is known to be overexpressed in a
number of cancers. Binding and internalization of anti-TSHR or
anti-EGFR NCs were tested by fluorescence microscopy in
human thyroid follicular control cells (Nthy-ori 3-1), cells derived
from a follicular carcinoma (FTC-133), and an anaplastic thyroid
cancer cell line (8505C).
Results and discussion: All tested antibodies directed to
TSHR and EGFR recognized thyroid cells as a monomolecular
antibody. However, when coupled to nano-sized carries systems,
only anti-EGFR nanocarriers bound efficiently to thyroid cells,
although with different binding patterns, depending on the cell
line. Furthermore, anti-EGFR NCs were internalized by thyroid
cells in culture, mainly in the case of anaplastic thyroid cancer
cell line. Our results provide an avenue to explore anti-EGFR
NCs as transporters to specifically deliver therapeutic agents to
thyroid cancer cells.
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Lung cancer is the most commonly diagnosed cancer in the world
and the first cause of death due to neoplastic disease. Despite
advances in diagnosis and treatment, prognosis still remeins unfa-
vourable.
Pyruvate kinase isozyme type M2 (PKM2), the enzyme catalyz-
ing the rate-limiting final step of glycolysis, is consistently altered
during tumorigenesis and is highly upregulated in tumors. More-
over, PKM2 promotes the Warburg effect. The aim of our study
was to investigate the expression of PKM2 in non-small cell lung
cancer (NSCLC) and in cancer associated fibroblasts (CAFs),
which are known to support tumor growth and may play a key
role in the acquisition of drug resistance in tumor cells.
The studies were conducted on 154 archival paraffin blocks of
NSCLC from patients treated in the Lower Silesia Centre of Pul-
monary Diseases in Wroclaw. Immunohistochemical reactions
with PKM2 antibody were performed on paraffin sections using
DAKO AutostainerLink 48. Expression of PKM2 was evaluated
using the semi-quantitative immunoreactive (IRS) scale of
Remmele and Stegner.
PKM2 was expressed significantly higher in NSCLC as com-
pared to tissues of adjacent non-malignant lung tissues (NMLT).
In NSCLC, PKM2 was expessed in cancer cells, as well as CAFs
and tumor associated macrophages (TAMs). PKM2 expression in
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